Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorKangbuk Samsung Hospital

About this trial

This study aimed to evaluate the effectiveness of use of Continuous Glucose Monitoring (CGM), combined with personalized dietary education and use of smartphone applications in improving glucose control and weight management.

Eligibility criteria

Qualifiers

Subjects over the age of 19

Patients with type 2 diabetes

Fasting blood glucose ≥ 126 mg/dL or

HbA1c ≥ 6.5% or

Disqualifiers

Subjects less than 19 years old

Patients with type 1 diabetes

Pregnant at the time of screening or planning to become pregnant during the study

Severe chronic diseases such as cancer, stroke, proliferative retinopathy, myocardial infarction, chronic renal disease, or amputation of a diabetic foot

Trial design

Treatments tested in this trial

  • Freestyle Libre

Treatment groups

420 Participants
are divided into 1 treatment group

Sponsors and collaborators

Kangbuk Samsung Hospital

Lead sponsor

Samsung Electronics

Collaborator